The kit is designed for detection of the tuberculosis and non-tuberculosis complex mycobacteria and their differentiation
The kit is designed for detection of mutations associated with drug resistance in the tuberculosis complex mycobacteria DNA with determination of sensitivity to the first-line chemotherapy drugs and their analogues.
The kit is designed to detect polymorphisms associated with drug resistance to second-line chemotherapy drugs (aminoglycosides and fluoroquinolones) and their analogues.
The kit is designed for qualitative and quantitative detection of human herpes simplex virus type 6 (HHV-6) DNA. It is used when examining patients with suspected herpes simplex virus infection and a confirmed diagnosis to assess viral load and evaluate the effectiveness of treatment.
The kit is recommended for use in patients with clinical symptoms of malaria with a suspected infection caused by representatives of the Plasmodium genus.
The kit is recommended for use in patients with clinical symptoms of malaria with a suspected infection caused by representatives of the Plasmodium genus.